Amarin Corp Plc (AMRN)

[Biobillionair]

Generic wing of FDA is responsible for blocking VASCEPA NCE...this same division of FDA promotes Hikma’s rancid API as “therapeutic equivalent” with an AB rating. Generic drug wing shared confidential legal position with Watson Labs in appeal of NCE “win” back in 2016.

Amarin needs to expose the crap API and if the FDA does nothing the generic drug wing should be abolished.

BB